GA
Genmab AS
🇺🇸XNAS.GMABUnited StatesHealthcare
$34.51USDup +0.37 (+1.08%)OpenDelayed6:02 PM
Price$34.51+0.37 (+1.08%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US3723032062
- CUSIP
- 372303206
Company
- Employees
- 3,119
- Headquarters
- Copenhagen, United States
- Website
- https://www.genmab.com
- CEO
- Dr. Jan G.J. van de Winkel Ph.D.
Market
- Shares outstanding
- 614.9M
- Market cap
- $21.22B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $20.99B
- EPS LTM
- $1.28
- P/E LTM
- 21.52
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4.13B-68.25%down year on year
- Net income
- $788.1M-85.61%down year on year
- Gross margin
- 93.03%-1.9%down year on year
- Free cash flow
- $867.34M-66.56%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.